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Collagen labelling with an azide-proline chemical
reporter in live cells†
Beatrice Amgarten,a Rakesh Rajan,b Nuria Martı´nez-Sa´ez,a Bruno L. Oliveira,c
Ineˆs S. Albuquerque,d Roger A. Brooks,b David G. Reid,a Melinda J. Duera and
Gonçalo J. L. Bernardes*ad
We have developed a strategy for selective imaging of collagen in
live foetal ovine osteoblasts. Our approach involves the incorpora-
tion of an azide-tagged proline in the biosynthesis of collagen
followed by labelling using a strain-promoted [3+2] azide–alkyne
cycloaddition reaction.
Collagen is the most abundant mammalian protein, accounting for
one third of all proteins and representing themajor component of the
extracellular matrix (ECM).1 The basic structure of collagen consists of
three single strands containing the repeating units Gly–Xaa–Yaa
which form a triple helix, where X and Y are predominantly proline
and hydroxyproline, respectively (both constitute approximately 23%
of the total of amino acids in collagen).2,3 Due to its high abundance
in collagen, proline has been widely exploited as a marker of collagen
biosynthesis by measuring incorporation of either radioactive or non-
radioactive isotopically-labelled proline (3H-Pro, 14C-Pro, 13C-Pro,
15N-Pro, cis-18F-Pro) as well as incorporation of heavy atoms (13C
and 15N) directly in tissues.3–5 Collagen plays a key role in many
pathogenic processes, as for example fibrosis6 and tumour growth
and metastasis,7 to mention the most prominent. Thus, we under-
took to exploit bioorthogonal strategies that would allow non-
invasive imaging of collagen structures and provide a powerful
imaging tool to monitor and study diseases where abnormal
collagen production is a main feature, including cirrhosis,
diabetic nephropathy or idiopathic pulmonary fibrosis.
Recent advances in bioorthogonal chemical reactions enables the
design of probes tailored for imaging tagged macromolecules.8,9
Using this approach, tagging and imaging of temporal and spatial
variations of the glycome,10 lipidome,11 as well as subsets of the
proteome12 have been successfully achieved. Proteome tagging can
be facilitated through the incorporation of non-canonical amino
acids bearing reactive handles using the host cell’s machinery.
Subsequent labelling with a fluorescent dye or radionuclide
by means of bioorthogonal reactions allows the visualisation
of newly synthesised proteins. Reactive metabolic precursors
applied previously for this purpose include the methionine
analogues azidohomoalanine13 and homopropargylglycine14
as well as the phenylalanine analogue ethynylphenylalanine.15
Azido-proline (N3-Pro) has been used for residue-specific
labelling of collagen model peptides by functionalization with
triazolyl moieties.16–18 Moreover, the incorporation fluoro-proline
was shown to enhance thermal stability of synthetic collagen
structures.19 Importantly, the introduction of modified proline
analogues still allows a collagen triple helix to form. Together these
examples highlight the potential of introducing proline-based
chemical reporters for the bioorthogonal imaging of collagen. Here,
we report the metabolic incorporation of N3-Pro as a chemical
reporter for the imaging of collagen using dibenzooctyne (DIBO)20
as a fluorescent probe and exploiting a strain promoted [3+2] azide–
alkyne cycloaddition (SPAAC) bioorthogonal reaction (Fig. 1). The
metabolic incorporation of a reporter group by foetal ovine osteo-
blasts was achieved by supplementation of the growth medium
with cis-4-azido-L-proline (ESI† for synthesis details).
We chose ovine osteoblasts as our model system to exploit
the bioorthogonal imaging of collagen in live cells because they have
been shown to behave similarly to human osteoblasts in terms of
viability, and osteocalcin and interleukin-6 production, compared to
other animal derived cells, making them a suitablemodel system for
our proposed investigations.21 Furthermore, since foetal ovine osteo-
blasts are not auxotrophic for proline –meaning that they are able to
synthesise proline themselves – the levels of incorporation in the
presence of the chemical reporter N3-Pro is expected to be lower than
in pulse-labelling. However, here wemake use of a low, physiological
concentration for osteoblast culturing which makes it relevant
for applications in in vivo models.
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We started by analysing the eﬀect on cell viability of culturing
foetal ovine osteoblasts in the presence of 18 mg L1 or 36 mg L1
of N3-Pro. The presence of N3-Pro had no eﬀect on cell viability
at either concentration (Fig. 2A and Fig. S1, ESI†). To assess
incorporation of N3-Pro into collagen, amino acid analysis by
HPLC and infrared spectroscopy on harvested ECM grown in
the absence or presence of N3-Pro was performed. Amino acid
analysis provided evidence of N3-Pro incorporation in the ECM
(Fig. S2, ESI†). Infrared spectral analysis further supports
incorporation of N3-Pro into ECM as a band attributed to the
stretching of the N3 group could be detected in the labelled
ECM samples as opposed to the unlabelled (Fig. S3, ESI†).
Next, we used fluorescence microscopy to image N3-Pro tagged
collagen in foetal ovine osteoblasts after SPAAC reaction with the
fluorescent probe DIBO (Fig. 2B and C). Cells were grown in the
presence or absence of 36 mg L1 of N3-Pro, fixed and stained
with 5 mM DIBO Alexa Fluor 555 for 60 min at room temperature
and counterstained with the nuclear dye Hoechst 33342 (Fig. 2C).
We found that foetal ovine osteoblasts cultured with N3-Pro and
bioorthogonally labelled with DIBO showed a nearly 2-fold
increase in fluorescence (Fig. 2B and C). Confocal microscopy
on stained foetal ovine osteoblast showed a dotted structure that
likely corresponds to non-secreted pro-collagen (Fig. S4, ESI†)
showing that the cells take up the azide-modified proline.
Fluorescent images showed, however, a relatively high back-
ground staining in the samples cultured in the absence of N3-Pro
(Fig. 2C, i–iii), indicating unspecific DIBO labelling. The DIBO
cyclooctyne fluorescent probe has been successfully applied in
bioorthogonal approaches based on SPAAC, although only in
imaging molecules densely presented on the cell surface.22 Given
the observed unspecific staining, we decided to analyse whether
DIBOwas reacting with intracellular proteins, by in-gel fluorescence
(Fig. S5, ESI†) and mass spectrometry analysis (Fig. S6, ESI†) of the
stained whole cell lysate. Despite previously reported selectivity of
cyclooctynes including DIBO for azides over thiols,20 mass spectro-
metry analysis of some of the most prominent bands in the gel
revealed unspecific labelling of intracellular structures such as
actin (Fig. S6, ESI†), suggesting unspecific reaction of the strained
alkyne probe with sulfhydryl-containing biomolecules.
In addition, bovine serum albumin (BSA), which is used as
a media supplement and blocking agent for the staining protocol
(Fig. S6, ESI†) was also detected. Bertozzi and co-workers also reported
the same issue in the in vivo imaging of glycoconjugates usingDIFO.23
In an attempt to reduce unspecific labelling, we pre-incubated fixed
samples with the thiol alkylating agent iodoacetamide (IAM) prior to
staining with DIBO.24 Indeed, in-gel fluorescence showed a reduction
of unspecific staining and an increase of background to signal ratio
(Fig. S5, ESI†), whichwas further confirmed by flow cytometry analysis
(Fig. 3 and Fig. S7, ESI†). Our observations indicate that the use of
the fluorescent probe DIBO in SPAAC bioorthogonal approaches
for imaging of molecules that are not densely presented on the
cell surface meets with some limitations, namely, its high
reactivity towards cellular and plasma sulfhydryl containing
biomolecules limiting its application to challenging structures
namely intracellular targets.
Finally, we wished to demonstrate that our approach did not
interfere with the normal growth of ECM in foetal ovine osteo-
blasts. Scanning electronmicroscopy images (SEM) of cells cultured
in the presence of N3-Pro confirmed adequate integrity (Fig. 4).
In summary, we report the metabolic incorporation of N3-Pro
into collagen and its use as a chemical reporter for bioorthogonal
Fig. 1 Incorporation of N3-Pro chemical reporter into collagen and
labelling using a strain-promoted azide–alkyne cycloaddition reaction
with the fluorescent probe DIBO.
Fig. 2 (A) Measurement of metabolic activity of foetal ovine osteoblasts
upon incubation with N3-Pro. Data was collected after 1 and 3 days. Error
bars represent the standard error of independent measurements from
3 diﬀerent cell culture wells. (B) Mean of total fluorescent intensity  SEM
in arbitrary units (a.u.) of foetal ovine osteoblasts cultured in the absence or
presence of 36 mg mL1 of N3-Pro upon staining with 5 mM DIBO-Alexa
Fluor 555. Statistically significant diﬀerences found after two-tailed Mann–
Whitney’s U test are marked as * (Po 0.05) and values are average  SEM.
(C) Fluorescence labelling of proteins with DIBO in foetal ovine osteoblasts
cultured in the absence (i–iii) or presence (iv–vi) of 36 mg L1 N3-Pro:
(i) and (iv) staining with 5 mM DIBO Alexa Fluor 555 (red); (ii) and (v) counter-
staining with Hoechst 33342 (blue); (iii) and (vi) overlay. DIBO-Alexa Fluor 555
has a peak excitation at 555 nm and a peak emission at 565 nm. Hoechst 33342
has a peak excitation at 350 nm and a peak emission at 461 nm. Scale bar
represents 20 mm.
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labelling using a SPAAC strategy in live foetal ovine osteoblasts. Our
data provides proof of principle for the use of proline derivatives
equipped with orthogonal handles, such as the azide here reported,
to tag and label collagen structures. The azide derivative was
successfully incorporated and labelled with the fluorescent probe
DIBO. Although our approach suﬀered from unspecific reaction of
the strained alkyne DIBOwith sulfhydryl rich proteins such as actin
or albumin, this was partially prevented by pre-incubation with
IAM. We are now exploring the incorporation of prolines equipped
with diﬀerent handles that would allow a more eﬃcient bioortho-
gonal labelling of collagen.
Our strategy could be particularly useful for the diagnosis and
monitoring of pathogenic accumulations of ECM. The develop-
ment of new therapies for fibrotic diseases (e.g. cirrhosis or
idiopathic pulmonary fibrosis characterized by excessive deposi-
tion of collagen) has been impeded by diﬃculties in assessing
eﬃcacy, since sensitive biomarkers of fibrogenesis/fibrolysis,
either in cells or animal models, are not available.6 The cellular
model described here could be used for example for high-
throughput screening of therapeutic agents by fluorescent
microplate-based analysis and help in the identification of lead
anti-fibrotic drugs from a series of candidates.
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Fig. 3 Eﬀect of pre-incubation with iodoacetamide (IAM) on fluores-
cence intensity of N3-Pro tagged foetal ovine osteoblasts. N3-Pro tagged
foetal ovine osteoblasts were treated with 5 mM IAM for 60 min prior to
staining with the DIBO probe. Results are normalized to the corresponding
negative controls (cells cultured in the absence of N3-Pro).
Fig. 4 Scanning electron microscopy of foetal ovine osteoblasts cultured
in the presence of 36 mg L1 of N3-Pro. Left: foetal ovine osteoblasts
integrity is adequate, one cell (white arrow) shows damage of the cell
membrane and its nucleus is visible. The other cells show membrane
extensions typical for cells in culture. Right: view of cells and ECM fibers
which are primarily collagen. Scale bars represent 20 mm.
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